Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis - PubMed (original) (raw)
Guideline
doi: 10.1002/ana.1032.
A Compston, G Edan, D Goodkin, H P Hartung, F D Lublin, H F McFarland, D W Paty, C H Polman, S C Reingold, M Sandberg-Wollheim, W Sibley, A Thompson, S van den Noort, B Y Weinshenker, J S Wolinsky
Affiliations
- PMID: 11456302
- DOI: 10.1002/ana.1032
Guideline
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis
W I McDonald et al. Ann Neurol. 2001 Jul.
Abstract
The International Panel on MS Diagnosis presents revised diagnostic criteria for multiple sclerosis (MS). The focus remains on the objective demonstration of dissemination of lesions in both time and space. Magnetic resonance imaging is integrated with dinical and other paraclinical diagnostic methods. The revised criteria facilitate the diagnosis of MS in patients with a variety of presentations, including "monosymptomatic" disease suggestive of MS, disease with a typical relapsing-remitting course, and disease with insidious progression, without clear attacks and remissions. Previously used terms such as "clinically definite" and "probable MS" are no longer recommended. The outcome of a diagnostic evaluation is either MS, "possible MS" (for those at risk for MS, but for whom diagnostic evaluation is equivocal), or "not MS."
Comment in
- Reply: To PMID 11456302.
Polman CH, Reingold SC, Weinshenker BG. Polman CH, et al. Ann Neurol. 2006 May;59(5):871. doi: 10.1002/ana.20849. Ann Neurol. 2006. PMID: 16634009 No abstract available.
Similar articles
- Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis.
Miller DH, Filippi M, Fazekas F, Frederiksen JL, Matthews PM, Montalban X, Polman CH. Miller DH, et al. Ann Neurol. 2004 Aug;56(2):273-8. doi: 10.1002/ana.20156. Ann Neurol. 2004. PMID: 15293279 Review. - [Diagnosis of multiple sclerosis: A review of the 2017 revisions of the McDonald criteria].
Csépány T . Csépány T . Ideggyogy Sz. 2018 Sep 30;71(9-10):321-329. doi: 10.18071/isz.71.0321. Ideggyogy Sz. 2018. PMID: 30335264 Review. Hungarian. - Revised diagnostic criteria of multiple sclerosis.
Milo R, Miller A. Milo R, et al. Autoimmun Rev. 2014 Apr-May;13(4-5):518-24. doi: 10.1016/j.autrev.2014.01.012. Epub 2014 Jan 12. Autoimmun Rev. 2014. PMID: 24424194 Review. - [Revision of McDonald's new diagnostic criteria for multiple sclerosis].
Wiendl H, Kieseier BC, Gold R, Hohlfeld R, Bendszus M, Hartung HP. Wiendl H, et al. Nervenarzt. 2006 Oct;77(10):1235, 1237-45. doi: 10.1007/s00115-006-2127-6. Nervenarzt. 2006. PMID: 16912904 German. - Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A, Frederiksen J, Enzinger C, Barkhof F, Gasperini C, Brownlee W, Drulovic J, Montalban X, Cramer SP, Pichler A, Hagens M, Ruggieri S, Martinelli V, Miszkiel K, Tintorè M, Comi G, Dekker I, Uitdehaag B, Dujmovic-Basuroski I, Rocca MA. Filippi M, et al. Lancet Neurol. 2018 Feb;17(2):133-142. doi: 10.1016/S1474-4422(17)30469-6. Epub 2017 Dec 21. Lancet Neurol. 2018. PMID: 29275979
Cited by
- Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patients.
Jendretzky KF, Lezius LM, Thiele T, Konen FF, Huss A, Heitmann L, Güzeloglu YE, Schwenkenbecher P, Sühs KW, Skuljec J, Wattjes MP, Witte T, Kleinschnitz C, Pul R, Tumani H, Gingele S, Skripuletz T. Jendretzky KF, et al. Neurol Res Pract. 2024 Nov 12;6(1):55. doi: 10.1186/s42466-024-00351-2. Neurol Res Pract. 2024. PMID: 39533435 Free PMC article. - White Matter Lesion Volumes on 3-T MRI in People With MS Who Had Followed a Diet and Lifestyle Program for More Than 10 Years.
Jaftha M, Robertson F, van Rensburg SJ, Kidd M, van Toorn R, Kemp MC, Johannes C, Moremi KE, Whati L, Kotze MJ, Engel-Hills P. Jaftha M, et al. Mult Scler Int. 2024 Nov 1;2024:8818934. doi: 10.1155/2024/8818934. eCollection 2024. Mult Scler Int. 2024. PMID: 39524062 Free PMC article. - Automated assessment of brain MRIs in multiple sclerosis patients significantly reduces reading time.
Sieber V, Rusche T, Yang S, Stieltjes B, Fischer U, Trebeschi S, Cattin P, Nguyen-Kim DL, Psychogios MN, Lieb JM, Sporns PB. Sieber V, et al. Neuroradiology. 2024 Dec;66(12):2171-2176. doi: 10.1007/s00234-024-03497-7. Epub 2024 Nov 8. Neuroradiology. 2024. PMID: 39514032 Free PMC article. - NEDA-state, psychological symptoms and quality of life are stable in natalizumab-treated multiple sclerosis patients: An up to 6-years long follow-up study.
Sandi D, Kokas Z, Kincses ZT, Füvesi J, Fricska-Nagy Z, Vörös E, Biernacki T, Vécsei L, Klivényi P, Bencsik K. Sandi D, et al. Heliyon. 2024 Oct 18;10(20):e39536. doi: 10.1016/j.heliyon.2024.e39536. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39502229 Free PMC article. - Effectiveness of Non-Pharmacological Interventions for Spasticity Management in Multiple Sclerosis: A Systematic Review.
Amatya B, Khan F, Song K, Galea M. Amatya B, et al. Ann Rehabil Med. 2024 Oct;48(5):305-343. doi: 10.5535/arm.240064. Epub 2024 Oct 31. Ann Rehabil Med. 2024. PMID: 39497494 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical